Search Results for: hemostasis

Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the FDA to market its Xpert HemosIL FII & FV test. The test detects Factor II (FII) and Factor V Leiden (FV) genetic variations associated with thrombophilia, an increased risk of blood clots (thrombosis).

Instrumentation Laboratory (IL) today announced that it has received 510(k) clearance from the FDA for its HemosIL Liquid Heparin assay.

Cepheid and Instrumentation Laboratory today announced that Health Canada has issued Cepheid a medical device license for its Xpert HemosIL FII & FV test.

BloodCenter of Wisconsin today announced the availability of a new DNA test to evaluate a persons risk for developing a serious and potentially life-threatening thrombosis (blood clot).